Edition:
United States

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

83.39USD
25 May 2018
Change (% chg)

$-0.91 (-1.08%)
Prev Close
$84.30
Open
$84.43
Day's High
$84.69
Day's Low
$82.86
Volume
51,047
Avg. Vol
139,989
52-wk High
$108.62
52-wk Low
$34.41

Select another date:

Thu, May 17 2018

CORRECTED-UPDATE 1-Loxo Oncology's targeted RET drug shows promise in early trial

CHICAGO, May 16 An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer originated, according to preliminary data from a small study released on Wednesday.

BRIEF-Blueprint Medicines Q1 Loss Per Share $1.29

* BLUEPRINT MEDICINES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Blueprint Medicines Q4 Loss Per Share $1.23

* BLUEPRINT MEDICINES REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Blueprint Medicines Prices Public Offering Of 3.70 Mln Shares At $81.00/Share

* BLUEPRINT MEDICINES ANNOUNCES PRICING OF PUBLIC OFFERING OF SHARES OF COMMON STOCK

BRIEF-Blueprint Medicines Announces Proposed Public Offering Of Shares Of Common Stock

* BLUEPRINT MEDICINES ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

Select another date: